| Name | Title | Contact Details |
|---|---|---|
Sue H |
Chief People & Administrative Officer | Profile |
Monique McGlinch |
Vice President, Customer Engagement | Profile |
Mark Greenwood |
Vice President, Imaging Product Development | Profile |
Sue Hulsmeyer |
Senior Director -Human Resources | Profile |
Sue Hulsmeyer |
Vice President of Human Resources and Corporate Communications | Profile |
Lipid Nutrition is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Halo Health’s mission is to streamline communication, so clinicians can focus on care. The Halo Clinical Collaboration Platform provides role-based collaboration that combines scheduling, teams, and communication on a unified platform; allowing the right information to get to the right person at the right time.
New Chapter, Inc. is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. New Chapter, Inc. is based in Brattleboro, VT. You can find more information on New Chapter, Inc. at www.new-chapter.com
At Fox Chase Cancer Center, defeating cancer is our calling. Fox Chase is one of the nation`s first dedicated cancer hospitals, and our researchers and physicians have made major contributions to scientific advancement since our establishment more than a century ago in 1904. Fox Chase scientists have made breakthroughs in cancer prevention, diagnosis, treatment, and survivorship, and have earned the highest awards in their fields, including two Nobel Prizes. We translate these pioneering discoveries into world-class clinical care every day - with a single purpose: to defeat cancer and help the people it impacts. This calling is rooted in our cancer-specific, multidisciplinary teams of doctors, researchers, practitioners, and five-time Magnet designated nurses, who are all more than specialists in cancer; they are international experts in distinct types of cancer, whose deep and focused expertise provides the best chance for the best outcome anywhere along the cancer continuum. And they`re helping to advance the way cancer treatment is delivered around the world. The way we work together, with this single, shared passion for our patients` well-being, is what makes us truly unique.
Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. Abeona’s lead program is an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB) in collaboration with patient advocate groups, researchers and clinicians. Clinical trials for Sanfilippo types A and B are anticipated to begin in 2015.